Los Angeles Capital Management LLC Purchases New Stake in Kymera Therapeutics, Inc. (NASDAQ:KYMR)
Los Angeles Capital Management LLC purchased a new position in Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 9,648 shares of the company’s stock, valued at approximately $246,000. A number of other large investors have […]
More Stories
Vipshop Holdings Limited (NYSE:VIPS) Receives $17.50 Average PT from Analysts
Shares of Vipshop Holdings Limited (NYSE:VIPS – Get Free Report) have earned a consensus rating of “Hold” from the seven...
Crown Castle (NYSE:CCI) and CubeSmart (NYSE:CUBE) Head to Head Review
CubeSmart (NYSE:CUBE – Get Free Report) and Crown Castle (NYSE:CCI – Get Free Report) are both finance companies, but which...
Contrasting Wynn Macau (OTCMKTS:WYNMY) and Civeo (NYSE:CVEO)
Civeo (NYSE:CVEO – Get Free Report) and Wynn Macau (OTCMKTS:WYNMY – Get Free Report) are both consumer discretionary companies, but...
Analysts Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) PT at $31.67
Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have earned a consensus rating of “Buy” from the seven...
Reviewing HUYA (NYSE:HUYA) & Nexxen International (NASDAQ:NEXN)
HUYA (NYSE:HUYA – Get Free Report) and Nexxen International (NASDAQ:NEXN – Get Free Report) are both small-cap computer and technology...
Brokerages Set indie Semiconductor, Inc. (NASDAQ:INDI) Price Target at $8.92
indie Semiconductor, Inc. (NASDAQ:INDI – Get Free Report) has been assigned an average rating of “Buy” from the six research...